Healthcare

passed · New Jersey · General Assembly Jun 30, 2026

A 3434: Creates "New Jersey Dialysis Patient Support Person Accommodation Act."

This bill (A 3434) requires New Jersey dialysis centers to allow patients receiving treatment to be accompanied by a designated support person who can assist with communication, mobility, and care decisions. It directly affects dialysis patients and the centers providing their treatment. Centers must create and display clear written policies for support person access, implement reasonable health/safety rules (without unnecessary restrictions), and train staff on these policies. The New Jersey Department of Health will enforce the law, investigate complaints about denied access, and impose penalties for non-compliance. The law takes effect immediately upon passage.

Topics ✓ HealthcareSupports HealthcareMandates dialysis centers to allow support persons for communication, mobility, and care decisions, directly improving patient access and rights in healthcare services.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · New Jersey · General Assembly Jun 30, 2026

A 2550: Requires continuation of health benefits dependent coverage for certain children with disabilities who are 26 years of age or older.

This bill requires health insurance plans in New Jersey to continue covering adult children with disabilities who are 26 or older, provided they cannot work due to a physical or intellectual disability and are financially dependent on their parent. It amends existing law to extend coverage beyond the standard age limit of 26 for this specific group, ensuring they maintain health insurance through their parent's plan. The bill prohibits denial of coverage based on factors like marriage, having a child, or school status, which commonly affected young adults with disabilities. This change directly impacts young adults with disabilities in New Jersey who would otherwise lose coverage at age 26 but meet the eligibility criteria.

Topics ✓ HealthcareSupports HealthcareExtends mandatory health insurance coverage for disabled adults over 26, ensuring continued access for vulnerable individuals who would otherwise lose benefits at age 26.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 23, 2026

A 1821: Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

This bill prohibits health insurance carriers from denying coverage for nonopioid pain medications in favor of opioids or requiring patients to try opioids first. It requires insurers to treat FDA-approved nonopioid drugs equally to opioids in formularies, meaning coverage restrictions, prior authorization, and cost-sharing tiers must be no more restrictive for nonopioid drugs. The law applies to state health benefit plans, school employee health programs, and Medicaid for acute pain treatment. It takes effect January 1, 2026, directly affecting insurers and patients covered by these plans.

Topics ✓ HealthcareSupports HealthcareProhibits insurers from favoring opioids over nonopioid drugs, ensuring equal coverage and access to alternative pain treatments under state plans and Medicaid.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 23, 2026

A 1207: Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services without restrictions for beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who seek infertility treatment. The key provision amends Medicaid law to explicitly include these services as a standard benefit, removing prior authorization requirements. This change would expand current coverage to ensure these treatments are accessible as routine care for eligible individuals.

Topics ✓ HealthcareSupports HealthcareExpands Medicaid coverage for infertility treatments by removing prior authorization, improving access to reproductive healthcare services.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 18, 2026

A 1142: Expands requirements for health insurance carriers concerning prostate cancer screening. *

This bill expands New Jersey's existing requirement for health insurance plans to cover prostate cancer screenings without any out-of-pocket costs. It specifically requires coverage for annual screenings - including digital rectal exams and PSA tests - for men aged 50 and older (asymptomatic) and men aged 40 and older with a family history of prostate cancer or other risk factors. The law applies to most health insurance plans, including high-deductible plans where permitted by federal law, and mandates coverage "to the same extent as for any other medical condition." It does not alter existing coverage for other preventive services but ensures no cost-sharing (like deductibles or copays) applies to these specific screenings.

Topics ✓ HealthcareSupports HealthcareExpands mandatory coverage for prostate cancer screenings without cost sharing, increasing patient access to preventive care as required by law.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 18, 2026

A 2001: Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.

This bill exempts drug manufacturers and distributors from New Jersey's pharmacy licensing requirements when distributing dialysate drugs and devices used for home dialysis treatment of end-stage renal disease patients. It directly affects dialysis manufacturers, distributors, and patients receiving home dialysis, allowing them to bypass standard pharmacy licensing rules under six specific conditions. Key provisions include requiring FDA approval, direct delivery only upon physician orders, original sealed packaging, and mandatory weekly quality checks by a consultant pharmacist. The law ensures these products are handled safely while streamlining access for patients needing home dialysis.

Topics ✓ HealthcareSupports HealthcareExempts manufacturers/distributors from pharmacy licensing for dialysis drugs, improving patient access to home dialysis by reducing regulatory barriers for essential end-stage renal disease treatment.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · New Jersey · General Assembly Jun 11, 2026

A 5059: Establishes crime of fertility fraud.

This New Jersey bill creates a new crime called fertility fraud, which specifically targets licensed health care practitioners who knowingly use a patient's reproductive material without their written consent. Under the law, a practitioner commits this offense if they use their own sperm or eggs or the material of another person to cause a pregnancy without the patient's informed agreement. If convicted of this third-degree crime, the individual faces up to five years in prison, a fine of $15,000, and the mandatory permanent revocation of their medical license. Additionally, the legislation extends the statute of limitations for prosecuting this specific offense to 20 years from the date of the treatment or 10 years from when the victim discovers the fraud, whichever is later.

Topics ✓ Criminal JusticeSupports Criminal JusticeBill creates a new crime to protect victims of fertility fraud, enhancing legal accountability and justice for reproductive rights violations.90% confidence ✓ HealthcareSupports HealthcareBill protects patient rights by criminalizing unauthorized use of reproductive material, strengthening trust in healthcare providers.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · New Jersey · General Assembly Jun 11, 2026

A 2268: Requires certain providers of substance or alcohol use disorder treatment, services, or supports to be assessed for conflicts of interest prior to receiving State funds, licensure, or certification.

This bill requires state agencies to assess substance and alcohol use disorder treatment providers for conflicts of interest before approving state funding, licensure, or certification. Providers must submit detailed financial information, board member details, and lists of stakeholders with financial ties. If a conflict is identified that could affect care quality, the provider has 90 days to resolve it or risk losing funding/approval. After resolution, providers must undergo two additional conflict assessments within the next year. The law applies to all licensed or certifying state entities and defines conflicts as situations where outside financial interests might influence treatment decisions.

Topics ✓ HealthcareSupports HealthcareRequires conflict-of-interest assessments for substance use disorder providers to protect care quality and prevent funding misuse, directly safeguarding patient interests in healthcare services.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 4, 2026

A 1510: Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*

This bill requires New Jersey's Medicaid managed care organizations to automatically include lower-cost generic and biosimilar drugs on their formularies with better cost-sharing (like lower copays) when they are cheaper than the original brand drugs. It directly affects insurers managing Medicaid plans and their enrollees, ensuring patients pay less for equivalent treatments. Key provisions mandate that if a generic drug's price is lower than its reference brand at launch, insurers must list it with favorable cost-sharing and remove barriers like prior authorization. The bill does not force insurers to stop covering brand drugs but ensures cheaper alternatives are prioritized for cost savings. It applies only when cheaper options are available and respects medical appropriateness decisions by insurers.

Topics ✓ Budget & TaxesSupports Budget & TaxesMandates Medicaid managed care to use cheaper drugs, reducing state spending on pharmaceuticals and promoting fiscal responsibility within Medicaid budget management.85% confidence ✓ HealthcareSupports HealthcareMandates lower-cost drug inclusion in Medicaid formularies, reducing patient copays and improving access to affordable treatments.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly May 28, 2026

A 5151: Prohibits surcharge on transportation network company riders for certain paratransit service.

This bill prohibits the $0.50 surcharge on rideshare trips that are designated for paratransit service, which includes transportation for people with disabilities and Medicaid non-emergency medical transport. It directly affects users of apps like Uber and Lyft who rely on these services for accessibility needs, ensuring they are not charged the extra fee required for regular prearranged rides. The legislation also clarifies that transportation network companies are not personally liable for these specific paratransit trips. By amending existing state laws, the bill removes the financial barrier for eligible riders while maintaining the surcharge for standard rides.

Topics ✓ HealthcareSupports HealthcareBill removes a surcharge on rideshare trips for paratransit, improving patient access to essential transportation services for people with disabilities and Medicaid recipients.85% confidence ✓ TransportationSupports TransportationBill removes a surcharge for paratransit rides, enhancing accessibility and protecting transportation services for people with disabilities.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track